We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SUN:ASXSuncorp Group Limited Analysis

Data as of 2026-05-24 - not real-time

A$17.51

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

The 20‑day simple moving average sits just above the 50‑day SMA, while the 200‑day SMA remains higher than the current trading level, suggesting a short‑term upward bias within a longer‑term neutral backdrop. RSI is in the low‑60s, indicating solid momentum without reaching overbought territory. MACD shows a bullish histogram and the signal line is below the MACD line, reinforcing positive price pressure. The stock’s beta is well below one, pointing to low sensitivity to broader market swings, and 30‑day volatility near the low‑20% range suggests moderate price swings. However, the price‑to‑earnings multiple sits above the industry average, implying a premium valuation at present.
Analyst sentiment leans toward a buy, with a target price modestly above the current level, while the dividend payout ratio exceeds 100%, raising questions about sustainability. The DCF‑derived fair value is markedly higher than today’s price, indicating potential upside if cash‑flow assumptions hold. Increasing volume trends support the technical bullish signals, but regulatory and insurance‑specific risks remain a consideration. Overall, the blend of technical strength, modest growth prospects, and valuation nuances points to a cautiously optimistic outlook.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD crossover with positive histogram
  • RSI indicating strong but not overbought momentum
  • Increasing volume supporting upward price pressure

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Modest revenue and earnings growth expectations
  • Current price near analyst target median
  • Dividend payout ratio above 100% creating sustainability concerns

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value suggests meaningful upside
  • Low beta and stable cash‑flow generation from insurance operations
  • Solid balance sheet with manageable leverage

Key Metrics & Analysis

Financial Health

Revenue Growth1.70%
Profit Margin6.54%
P/E Ratio21.1
ROE8.40%
ROA2.83%
Debt/Equity22.54
P/B Ratio1.9
Op. Cash FlowA$1.7B
Free Cash FlowA$2.3B
Industry P/E16.8

Technical Analysis

TrendNeutral
RSI61.6
SupportA$16.46
ResistanceA$17.83
MA 20A$17.13
MA 50A$16.54
MA 200A$17.99
MACDBullish
VolumeIncreasing
Fear & Greed Index91.61

Valuation

Fair ValueA$29.06
Target PriceA$18.73
Upside/Downside6.98%
GradeFair
TypeBlend
Dividend Yield1.94%

Risk Assessment

Beta0.18
Volatility20.97%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.